Form 4 for MDGL MADRIGAL PHARMACEUTICALS, INC.
Accepted 2023-01-19 00:00:00 ET · period of report 2023-01-17 · accession 0000899243-23-002219 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-01-19 | 2023-01-17 | MDGL | Levy Richard S | Dir | M - OptEx | $103.02 | +22.5K | 21.6K | New | +$2.32M |
| DM | 2023-01-19 | 2023-01-17 | MDGL | Levy Richard S | Dir | S - Sale+OE | $293.15 | -22.5K | 31.5K | -42% | -$6.59M |
| DM | 2023-01-19 | 2023-01-17 | MDGL | Levy Richard S | Dir | M - OptEx | $0.00 | -22.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-17 | M | A | 10,000 | $100.45 | 31,589 | D | — | — | |
| 2 | Common | Common Stock | 2023-01-17 | S | D | 500 | $296.68 | 9,100 | D | — | — | (F12) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $296.43 to $296.77, inclusive. |
| 3 | Common | Common Stock | 2023-01-17 | S | D | 2,325 | $295.45 | 9,600 | D | — | — | (F11) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $295.26 to $296.15, inclusive. |
| 4 | Common | Common Stock | 2023-01-17 | S | D | 5,164 | $294.68 | 11,925 | D | — | — | (F10) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $294.17 to $295.16, inclusive. |
| 5 | Common | Common Stock | 2023-01-17 | S | D | 3,548 | $293.54 | 17,089 | D | — | — | (F9) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $293.12 to $294.11, inclusive. |
| 6 | Common | Common Stock | 2023-01-17 | S | D | 5,227 | $292.68 | 20,637 | D | — | — | (F8) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $292.11 to $293.09, inclusive. |
| 7 | Common | Common Stock | 2023-01-17 | S | D | 3,325 | $291.66 | 25,864 | D | — | — | (F7) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $291.08 to $292.07, inclusive. |
| 8 | Common | Common Stock | 2023-01-17 | S | D | 1,600 | $290.36 | 29,189 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $289.80 to $290.79, inclusive. |
| 9 | Common | Common Stock | 2023-01-17 | S | D | 300 | $288.91 | 30,789 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $288.73 to $289.01, inclusive. |
| 10 | Common | Common Stock | 2023-01-17 | S | D | 400 | $287.08 | 31,089 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $286.99 to $287.16, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below. |
| 11 | Common | Common Stock | 2023-01-17 | S | D | 100 | $285.28 | 31,489 | D | — | — | |
| 12 | Common | Common Stock | 2023-01-17 | M | A | 12,489 | $105.08 | 21,589 | D | — | — | |
| 13 | Derivative | Stock Option (Right to buy) | 2023-01-17 | M | D | 12,489 | $0.00 | 0 | D | $105.08 · — to 2024-06-17 | 12,489 Common Stock | (F2) All shares issued pursuant to the exercise of these options represent 12,489 shares underlying an option award of 12,489 shares. All exercised options vested June 17, 2022. |
| 14 | Derivative | Stock Option (Right to Buy) | 2023-01-17 | M | D | 10,000 | $0.00 | 0 | D | $100.45 · — to 2024-06-27 | 10,000 Common Stock | (F3) All shares issued pursuant to the exercise of these options represent 10,000 shares underlying an option award of 10,000 shares. All exercised options vested June 27, 2020. |